Dietetic effects of oral intervention with mare's milk on the Severity Scoring of Atopic Dermatitis, on faecal microbiota and on immunological parameters in patients with atopic dermatitis

References

• Andersson Y, Lindquist S, Lagerqvist C, Hernell O. Lactoferrin is responsible for the fungistatic effect of human milk. Early Hum Dev 2000; 59: 95–105
   PubMed Web of Science ®Google Scholar
• Angelova-Fischer I, Hipler UC, Bauer A, Fluhr JW, Tsankov N, Fischer TW, Elsner P. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis—from laboratory parameters to clinical scores. Br J Dermatol 2006; 154: 1112–1117
   PubMed Web of Science ®Google Scholar
• Bahmer FA, Schaefer J. Treatment of atopic dermatitis with borage seed oil (Glandol)— a time series analytic study. Kinderaerztl Praxis 1992; 60: 199–202
   PubMedGoogle Scholar
• Breuer K, Kapp A, Werfel T. Urine eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis of the adult age. Allergy 2001; 56: 780–784
   PubMedGoogle Scholar
• Buehlbaecker, A. 1996. Zur Verwendbarkeit von Stutenmilch, Kumyss und Eselmilch als Dietetika und Heilmittel unter besonderer Beruecksichtigung der Beduerfnisse des Saeuglings und des Fruehgeborenen. Thesis, Privat-Univ. Witten, Herdecke, Verlag Haensel-Hohenhausen, Frankfurt am Main.
   Google Scholar
• Caccavo D, Pellegrino NM, Altamura M, Rigon A, Amati L, Amoroso A, Jirillo E. Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application. J Endotoxin Res 2002; 8: 403–417
   PubMedGoogle Scholar
• Consensus Report of the European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993; 186: 23–31
   PubMedGoogle Scholar
• Cruikshank W, Kornfeld H, Certer D. Interleukin-16. J Leukoc Biol 2000; 67: 757–766
   PubMed Web of Science ®Google Scholar
• Czech W, Krutmann J, Schoepf E, Kapp A. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 1992; 126: 351–355
   PubMed Web of Science ®Google Scholar
• Ellinger S, Linscheid KP, Jahnecke S, Goerlich R, Enbergs H. The effect of mare's milk consumption on functional elements of phagocytosis of human neutrophil granulocytes from healthy volunteers. Food Agric Immunol 2002; 14: 191–200
   Web of Science ®Google Scholar
• Frezzolini A, Paradisi M, Zaffiro A, Provini A, Cadoni S, Ruffelli M, De Pità O. Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity. Allergy 2002; 57: 815–820
   PubMed Web of Science ®Google Scholar
• Furue M, Koga T, Yamashita N. Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis. Br J Dermatol 1999; 140: 67–72
   PubMed Web of Science ®Google Scholar
• Gall H, Kalveram CM, Sick H, Sterry W. Allergy to the heat-labile proteins α-lactalbumin and β-lactoglobulin in mare's milk. J Allergy Clin Immunol 1996; 97: 1304–1307
   PubMedGoogle Scholar
• Grover M, Giouzeppos O, Schnagl RD, May JT. Effect of human milk prostaglandins and lactoferrin on respiratory syncytial virus and rotavirus. Acta Paediatr 1997; 86: 315–316
   PubMedGoogle Scholar
• Harmsen HJM, Elfferich P, Schut F, Welling GW. A 16 S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis 1999; 11: 3–12
   Google Scholar
• Hatzipanagiotou A, Rieland E, Enbergs H. The activity of lysozyme in the milk of sucking mares during the lactation period. Deut Tierarztl Wochenschr 1998; 105: 148–152
   PubMedGoogle Scholar
• He F, Morita H, Ouwehand AC, Hosoda M, Hiramatsu M, Kurisaki J, Isolauri E, Benno Y, Salminen S. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol Immunol 2002; 46: 781–785
   PubMed Web of Science ®Google Scholar
• Henz BM, Jablonska S, van de Kerkhof PC, Stingl G, Blaszczyk M, Vandervalk PG, Veenhuizen R, Muggli R, Raederstorff D. Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol 1999; 140: 685–688
   PubMedGoogle Scholar
• Ibrahim HR, Aoki T. New promises of lysozyme as immune modulator and antimicrobial agent for nutraceuticals. Foods Food Ingredients J Jpn 2003; 208: 361–374
   Google Scholar
• Kaegi MK, Joller-Jemelka H, Wuethrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 1992; 185: 88–92
   PubMedGoogle Scholar
• Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y,  Saeki H, Torii H, Komine M, Asahina A, Tamaki K. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin Exp Immunol 2002; 127: 270–273
   PubMed Web of Science ®Google Scholar
• Kalliomaeki M, Isolauri E. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 2003; 3: 15–20
   PubMedGoogle Scholar
• Kaminishi K, Soma Y, Kawa Y, Mizoguchi M. Flow cytometric analysis of IL-4, IL-13 and IFN-gamma expression in peripheral blood mononuclear cells and detection of circulating IL13 in patients with atopic dermatitis provide evidence for the involvement of type 2 cytokines in the disease. J Dermatol Sci 2002; 29: 19–25
   PubMed Web of Science ®Google Scholar
• Kim WS, Ohashi M, Tanaka T, Kumura H, Kim GY, Kwon IK, Goh JS, Shimazaki K. Growth-promoting effects of lactoferrin on L. acidophilus and Bifidobacterium spp. Biol Metals 2004; 17: 279–283
   Google Scholar
• Klein A, Friedrich U, Vogelsang H, Jahreis G. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur J Clin Nutr 2008; 62: 584–593
   PubMed Web of Science ®Google Scholar
• Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MHF, Welling GW. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Eviron Microb 1995; 61: 3069–3075
   PubMed Web of Science ®Google Scholar
• Laouini D, Alenius H, Bryce P, Oettghen H, Tsitsikov E, Geha RS. OL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest 2003; 112: 1058–1066
   PubMedGoogle Scholar
• Laske N, Niggemann B. Does the severity of atopic dermatitis correlate with serum IgE levels?. Pediatr Allergy Immunol 2004; 15: 86–88
   PubMed Web of Science ®Google Scholar
• Lee-Huang S, Huang PL, Sun Y, Huang PL, Kung HF, Blithe DL, Chen HC. Lysozyme and RNase as anti-HIV components in β-core preparations of human chorionic gonadotropin. Biochemistry 1999; 96: 2678–2681
   Google Scholar
• Leitch EC, Willox MD. Synergic antistaphylococcal properties of lactoferrin and lysozyme. J Med Microbiol 1998; 47: 837–842
   PubMed Web of Science ®Google Scholar
• Maneva A, Taleva B, Maneva L. Lactoferrin-protector against oxidative stress and regulator of glycolysis in human erythrocytes. Z. Naturforsch 2003; 58: 256–262
   Google Scholar
• Marchetti M, Longhi C, Conte MP, Pisani S, Valenti P, Seganti L. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral Res 1996; 29: 221–231
   PubMed Web of Science ®Google Scholar
• Murakami F, Sasaki T, Sugahara T. Lysozyme stimulates immunoglobulin production by human-human hybridoma and human peripheral blood lymphocytes. Cytotechnology 1997; 24: 177–182
   PubMed Web of Science ®Google Scholar
• Ogundele MO. A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation. Mediat Inflamm 1998; 7: 363–365
   PubMed Web of Science ®Google Scholar
• Orla MC. Antiinflammatory activities of lactoferrin. J Am Coll Nutr 2001; 20: S389–S395
   Google Scholar
• Orsi N. The antimicrobial activity of lactoferrin: current status and perspectives. Biometals 2004; 17: 189–196
   PubMed Web of Science ®Google Scholar
• Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 2001; 108: 144–145
   PubMed Web of Science ®Google Scholar
• Pahud JJ, Mach JP. Equine secretory IgA and secretory component. Int Arch Allergy 1972; 42: 175–186
   Google Scholar
• Pucci N, Lombardi E, Novembre E, Farina S, Bernardini R, Rossi E, Favilli T, Vierucci A. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity. J Allergy Clin Immunol 2000; 105: 353–357
   PubMed Web of Science ®Google Scholar
• Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111: 389–395
   PubMed Web of Science ®Google Scholar
• Sandomirsky BP, Galchenko SE, Galchenko KS. Antioxidative properties of lactoferrin from bovine colostrum before and after its lyophilization. Cryo Lett 2003; 24: 275–280
   PubMedGoogle Scholar
• Sava G, Ceschia V, Pacor S. Mechanism of the antineoplastic action of lysozyme: evidence for host mediated effects. Anticancer Res 1989; 9: 1175–1180
   PubMedGoogle Scholar
• Sistek D, Kelly R, Wickens K, Stanley T, Fitzharris P, Crane J. Is the effect of probiotics on atopic dermatitis confined to food sensitized children?. Clin Exp Allergy 2006; 36: 629–633
   PubMed Web of Science ®Google Scholar
• Solaroli G, Pagliarini E, Peri C. Composition and nutritional quality of mare's milk. Ital J Food Sci 1993; 1: 3–10
   Google Scholar
• Steward JCM, Morse PF, Moss M, Horrobin DF, Burton JL, Douglas WS, Gould DJ, Grattan CEH, Hindson TC, Anderson J, Jansén CT, Kennedy CTC, Lindskov R, Strong AMM, Wright S. Treatment of severe and moderately severe atopic dermatitis with evening primrose oil (Epogam): a multicentre study. J Nutr Med 1991; 2: 9–15
   Google Scholar
• Tischendorf FW, Brattig NW, Lintzel M, Buettner DW, Burchard GD, Bork K, Mueller M. Eosinophil granule proteins in serum and urine of patients with helminth infections and atopic dermatitis. Trop Med Int Health 2000; 5: 898–905
   PubMedGoogle Scholar
• Tobgi RS, Samaranayake LP, MacFarlane TW. In vitro susceptibility of Candida species to lysozyme. Oral Microbiol Immunol 1988; 3: 35–39
   PubMedGoogle Scholar
• Togawa JI, Nagase H, Tanaka K, Inamori M, Umezawa T, Nakajima A, Naito M, Sato S, Saito T, Sekihara H. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Am J Physiol Gastrointest Liver Physiol 2002; 283: 187–195
   PubMed Web of Science ®Google Scholar
• Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005; 60: 494–500
   PubMed Web of Science ®Google Scholar
• Wallace AB. The exposure treatment of burns. Lancet 1951; 1: 501–504
   PubMedGoogle Scholar
• Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tajiri Y, Kumemura M. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 2003; 111: 587–591
   PubMed Web of Science ®Google Scholar